Vadadustat for treating symptomatic anaemia in adults having dialysis for chronic kidney disease | TA1035 | | |
Acute kidney injury: prevention, detection and management | NG148 | | |
Empagliflozin for treating chronic kidney disease | TA942 | | |
Acute kidney injury | QS76 | | |
Finerenone for treating chronic kidney disease in type 2 diabetes | TA877 | | |
PromarkerD for predicting the risk of diabetic kidney disease in people with type 2 diabetes | MIB312 | | |
Imlifidase for desensitisation treatment before kidney transplant in people with chronic kidney disease | TA809 | | |
Roxadustat for treating symptomatic anaemia in chronic kidney disease | TA807 | | |
Dapagliflozin for treating chronic kidney disease | TA775 | | |
Chronic kidney disease: assessment and management | NG203 | | |
DyeVert Systems for reducing the risk of acute kidney injury in coronary and peripheral angiography | MTG60 | | |
RenalSense Clarity RMS for acute kidney injury | MIB256 | | |
Electrical stimulation to improve muscle strength in chronic respiratory conditions, chronic heart failure and chronic kidney disease | IPG677 | | |
Tests to help assess risk of acute kidney injury for people being considered for critical care admission (ARCHITECT and Alinity i Urine NGAL assays, BioPorto NGAL test and NephroCheck test) | DG39 | | |
Point-of-care creatinine devices to assess kidney function before CT imaging with intravenous contrast | DG37 | | |
StoneChecker for kidney stone evaluation | MIB171 | | |
Robot-assisted kidney transplant | IPG609 | | |
Minimally invasive percutaneous nephrolitholapaxy medium (MIP-M) for removing kidney stones | MIB138 | | |
Immunosuppressive therapy for kidney transplant in adults | TA481 | | |
Immunosuppressive therapy for kidney transplant in children and young people | TA482 | | |
Chronic kidney disease in adults | QS5 | | |
Multiple frequency bioimpedance devices to guide fluid management in people with chronic kidney disease having dialysis | DG29 | | |
C3 glomerulopathy in the native kidney: eculizumab | ESUOM49 | | |
Tolvaptan for treating autosomal dominant polycystic kidney disease | TA358 | | |
The NxStage System One NX1000‑1 home haemodialysis device for renal replacement therapy in chronic kidney disease | MIB12 | | |
The NGAL Test for early diagnosis of acute kidney injury | MIB3 | | |
Machine perfusion systems and cold static storage of kidneys from deceased donors | TA165 | | |